Vaxxinity Stock Forecast, Price & News

Vaxxinity (NASDAQ:VAXX) Frequently Asked Questions

Is Vaxxinity a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vaxxinity in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Vaxxinity stock.
View analyst ratings for Vaxxinity or view top-rated stocks.

When is Vaxxinity's next earnings date?

Vaxxinity is scheduled to release its next quarterly earnings announcement on Thursday, March 24th 2022.
View our earnings forecast for Vaxxinity.

How were Vaxxinity's earnings last quarter?

Vaxxinity Inc (NASDAQ:VAXX) announced its quarterly earnings results on Wednesday, December, 22nd. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.12.
View Vaxxinity's earnings history.

What price target have analysts set for VAXX?

2 equities research analysts have issued 1 year target prices for Vaxxinity's shares. Their forecasts range from $18.00 to $21.00. On average, they expect Vaxxinity's stock price to reach $19.50 in the next year. This suggests a possible upside of 145.6% from the stock's current price.
View analysts' price targets for Vaxxinity or view top-rated stocks among Wall Street analysts.

Who are some of Vaxxinity's key competitors?

Some companies that are related to Vaxxinity include Cerevel Therapeutics (CERE), Galapagos (GLPG), Arvinas (ARVN), ACADIA Pharmaceuticals (ACAD), Apellis Pharmaceuticals (APLS), Karuna Therapeutics (KRTX), Intra-Cellular Therapies (ITCI), Hypera (HYPMY), EQRx (EQRX), OPKO Health (OPK), Dicerna Pharmaceuticals (DRNA), Prestige Consumer Healthcare (PBH), PTC Therapeutics (PTCT), Pacira BioSciences (PCRX) and Zentalis Pharmaceuticals (ZNTL).
View all of VAXX's competitors.

When did Vaxxinity IPO?

(VAXX) raised $90 million in an initial public offering (IPO) on Thursday, November 11th 2021. The company issued 6,000,000 shares at $14.00-$16.00 per share.

What is Vaxxinity's stock symbol?

Vaxxinity trades on the NASDAQ under the ticker symbol "VAXX."

When did the company's quiet period expire?

Vaxxinity's quiet period expired on Tuesday, December 21st. Vaxxinity had issued 6,000,000 shares in its public offering on November 11th. The total size of the offering was $78,000,000 based on an initial share price of $13.00. During the company's quiet period, underwriters and any insiders that worked on the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Vaxxinity?

Shares of VAXX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vaxxinity's stock price today?

One share of VAXX stock can currently be purchased for approximately $7.94.

How much money does Vaxxinity make?

Vaxxinity has a market capitalization of $995.63 million and generates $560 thousand in revenue each year.

How many employees does Vaxxinity have?

Vaxxinity employs 2,021 workers across the globe.

What is Vaxxinity's official website?

The official website for Vaxxinity is www.vaxxinity.com.

How can I contact Vaxxinity?

The company can be reached via phone at 254-244-5739 or via email at [email protected].